NewsNovo CEO signals M&A opportunities to strengthen drug pipeline Posted on September 22, 2026 by budd87309@gmail.com Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market. budd87309@gmail.com Trump to press Zelenskyy for energy truce, says Russia has ‘lost control’ of oil due to Ukraine war
